UBS Group Ag ADR UBS

$46.87 -1.06 (-2.21%)

Valuation

Market cap
149,731,648,000
Revenue TTM
$76,118,000,000
Net income TTM
$7,767,000,000
PE ratio
16.06
Forward PE
13.16
Profit margin
10.20%
Debt to equity
3.84

Trading

Volume
2,090,200
Avg volume
1,892,978
Day's range
$46.62 – $47.56
Shares out
3,123,965,000
Stochastic %K
10%
Beta
1.21
Analysts
Strong Sell
Price target
$58.80

Price

Company profile

UBS Group AG operates as a wealth manager and bank worldwide. It operates through five segments: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-Core and Legacy. The Global Wealth Management segment offers financial services, advice, and solutions; investment management, estate planning, and corporate advice services; and wealth management and banking products and se...

Show more

UBS Group AG operates as a wealth manager and bank worldwide. It operates through five segments: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-Core and Legacy. The Global Wealth Management segment offers financial services, advice, and solutions; investment management, estate planning, and corporate advice services; and wealth management and banking products and services to private wealth and institutional customers. Its Personal & Corporate Banking segment provides banking, retirement, financing, investments, and strategic transactions to private, corporate, and institutional customers through its branch network and digital channels in Switzerland. The Asset Management segment offers diversified asset management services. Its Investment Bank segment provides equities, foreign exchange, precious metals, research, advisory, and capital markets services to institutional, corporate, financial sponsor, and Global Wealth Management customers, as well as focused rates and credit platform. The company also offers lending products, such as securities-based lending, mortgages, structured products, and tailored solutions; collateralized lending residential and commercial real estate, primarily against securities, residential and commercial real estate, other real assets (such as ships and aircraft), private market and hedge fund interest; and unsecured lending. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.

Industry
Banks - Diversified
Sector
Financial Services
Phone
41 44 234 11 11
Website
https://www.ubs.com
Address
Bahnhofstr. 45, P.O. Box, Zurich, Switzerland

Latest news

Stocktwits

OMillionaires Oct 23, 10:22 AM
$CRWV PT lowered to $105 from $120 at $UBS - keeps Buy rated
1 replies
tommyedwards Oct 21, 12:15 PM
$AMC "If $AMC exceeds $19.X, current authorized, non-issued 207M AMC shares allow #AMC management to pay back all corporate debt at their own leisure. Assuming $UBS offshore short position is larger than that, this means ATH in a squeeze scenario is determined by apes’ ability to HODL." https://x.com/vikstrom_stefan/status/2112862249136357566
0 replies
ThisStockisDogShit Oct 21, 11:57 AM
$GME $UBS on they’re way out of Switzerland 🇨🇭
0 replies
topstockalerts Oct 19, 12:50 PM
UBS named Convatec, Smith & Nephew, and Sonova its top risk-reward picks ahead of Q3 earnings, expecting European medtech revenue and profit growth to accelerate with favorable currency effects. Convatec: UBS expects 6% organic growth in H2 and reaffirmation of 5.5%–6.5% growth guidance and a 23% margin. Investors will watch updates on ConvaNiox, an FDA warning and the CFO search. Its £3.75 price target implies 71% upside from 220 pence. Smith & Nephew: UBS sees limited downside risk to Q3 consensus estimates ahead of November 4 results, while a potential strategic review could attract investors. Consensus forecasts 3.75% organic growth, but fund managers expect around 3.5% and remain concerned about another guidance cut. UBS expects U.S. knee sales to decline no more than 5% and anticipates a recovery in Wound Devices. Its £11.20 target implies 10% upside. $UBS
0 replies
topstockalerts Oct 16, 11:47 PM
Thoma Bravo-backed Proofpoint has secured $1.25 billion in financing to support its acquisition of cybersecurity company Varonis Systems, according to Bloomberg, citing people familiar with the matter. JPMorgan Chase and UBS have been appointed to lead a high-yield bond sale at a later date, providing an additional source of funding for the transaction. The acquisition is expected to close in the first half of 2027. Proofpoint agreed on Thursday to acquire Varonis for $49.75 per share in cash, valuing the cybersecurity company at approximately $6.3 billion. Thoma Bravo will contribute equity financing to support the purchase, while Ontario Teachers’ Pension Plan has also agreed to invest in Proofpoint as part of the funding package. The transaction also highlights continued access to debt markets for large private-equity-backed deals, with JPMorgan and UBS expected to manage the future high-yield offering. $JPM $UBS $VRNS
0 replies
OpenOutcrier Oct 16, 12:38 PM
$UBS (+0.7% pre) UBS exploring options abroad in case Swiss rules prove intolerable, sources say https://ooc.bz/l/117501
0 replies
topstockalerts Oct 12, 9:12 PM
Unison Co., a pioneer in residential home-equity sharing agreements, has selected UBS and Cantor Fitzgerald as lead underwriters for a planned U.S. IPO that could raise up to $500 million, Bloomberg reported. The San Francisco-based company could go public as early as November, although underwriting arrangements and timing remain subject to change. Unison provides homeowners with upfront cash in exchange for a share of their home’s future appreciation, offering an alternative to traditional home-equity loans amid elevated mortgage rates. Instead of making recurring monthly payments, homeowners settle the obligation in a lump sum when they sell or refinance their property. The potential IPO comes as institutional investors show growing interest in alternative real estate financing models. The listing could provide a public-market benchmark for consumer adoption of home-equity sharing as borrowers seek liquidity without increasing their monthly debt obligations. $UBS
0 replies
topstockalerts Oct 12, 8:37 PM
Wall Street’s dispersion trades face a critical test as major technology and semiconductor companies report earnings. Falling individual-stock volatility has hurt the strategy, leaving some hedge funds with losses as both implied and realized volatility premiums relative to the S&P 500 have narrowed. Traders hope earnings surprises, particularly around AI demand and semiconductor capital spending, will trigger stronger stock-specific movements. Dispersion strategies typically involve buying volatility in individual stocks while selling index volatility, betting that companies will move differently. Adapt Investment Managers’ Alexis Maubourguet said positions rebuilt after July’s pullback are now under pressure as investor conviction in AI-driven gains weakens. UBS strategist Kieran Diamond noted that options markets are pricing in the largest single-day earnings reactions since the COVID-19 pandemic, particularly for technology stocks. $SPX $UBS $NVDA $AMZN
0 replies